Sanofi’s equity ownership is widely distributed among major institutional investors, asset management firms, and public shareholders on international stock exchanges. Prominent global institutional entities, mutual funds, and large financial management groups hold substantial blocks of Sanofi shares, ensuring a diversified global investor base without a single controlling private majority owner.